Literature DB >> 2211032

Electrophysiological and psychophysical flicker sensitivity in patients with primary open-angle glaucoma and ocular hypertension.

K Holopigian1, W Seiple, C Mayron, R Koty, M Lorenzo.   

Abstract

Temporal sensitivity was assessed in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OHT). Three measures of flicker sensitivity were obtained: psychophysical modulation thresholds, visual-evoked potentials (VEPs), and focal electroretinograms (FERGs). We found elevated psychophysical thresholds at higher temporal frequencies (30-50 Hz) in patients with POAG, relative to thresholds for age-matched controls. The OHT patients had elevated psychophysical thresholds only at 50 Hz. On the other hand, VEP amplitudes in POAG patients were reduced at all temporal frequencies, with the magnitude of the loss increasing with temporal frequency. The OHT patients, however, showed no reductions in VEP amplitude at any temporal frequency. Finally, POAG patients' FERG amplitudes were reduced at 30-50 Hz; whereas FERG amplitudes in the OHT patients were normal at all temporal frequencies. These results indicate that OHT patients can exhibit psychophysical threshold losses at high temporal frequencies which are not observed in the suprathreshold electrophysiological amplitude measures. On the other hand, patients with POAG show both psychophysical and VEP losses across a range of temporal frequencies. In addition, the decreases in FERG amplitudes in POAG patients suggest changes in the functioning of the outer retina in this disease.

Entities:  

Mesh:

Year:  1990        PMID: 2211032

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

1.  [Importance of flicker contrast tests in functional glaucoma diagnostics].

Authors:  K Göbel; C M Poloschek; C Erb; M Bach
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

2.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 3.  [Functional disorders in the chronological progression of glaucoma].

Authors:  Carl Erb
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

4.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

5.  Neural conduction in the visual pathways in ocular hypertension and glaucoma.

Authors:  V Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

6.  Temporal contrast sensitivity with peripheral and central stimulation in glaucoma diagnosis.

Authors:  I M Velten; M Korth; F K Horn; W M Budde
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

7.  Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT.

Authors:  Li Guo; Eduardo M Normando; Shereen Nizari; David Lara; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

8.  Foveal cone photoreceptor involvement in primary open-angle glaucoma.

Authors:  Martijn J Kanis; Hans G Lemij; Tos T J M Berendschot; Jan van de Kraats; Dirk van Norren
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-07       Impact factor: 3.117

9.  Electro-oculogram changes in patients with ocular hypertension and primary open-angle glaucoma.

Authors:  L Mehaffey; K Holopigian; W Seiple
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

10.  Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice.

Authors:  Manuel Salinas-Navarro; Luis Alarcón-Martínez; Francisco Javier Valiente-Soriano; Arturo Ortín-Martínez; Manuel Jiménez-López; Marcelino Avilés-Trigueros; María Paz Villegas-Pérez; Pedro de la Villa; Manuel Vidal-Sanz
Journal:  Mol Vis       Date:  2009-12-05       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.